Paytient
Columbia, US · Founded 2018 · Delaware corporation · 11 known investors
Paytient is a platform that removes out-of-pocket costs as a barrier to healthcare access, allowing patients to choose care without financial burden while ensuring providers receive full payment and employers control costs. The platform serves employers, health plans, and individuals seeking to improve healthcare affordability and outcomes.
Also known as Paytient Technologies
Founders & leadership
Paytient was founded in 2018 by Brian Whorley and Daniel Lynn.
Board
Investors · 11
Also in the syndicate · 4
Reported raises · per SEC filings
Form D private placements$53.9M disclosed across 3 of 4 rounds · 2020–2023
▶$17.2MraisedJan 2023 · 10 investors · OtherRule 506(b)
- Joe KaiserDirector
- Brian WhorleyExecutive Officer, Director
- Darius ChehrzadDirector
- Daniel LynnDirector
- Jodi HublerDirector
- Charlotte RossDirector
- Offering amount
- $17.2M
- Amount sold
- $17.2M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$32.8MraisedJan 2023 · 7 investors · OtherRule 506(b)
- Charlotte RossDirector
- Joe KaiserDirector
- Darius ChehrzadDirector
- Jodi HublerDirector
- Daniel LynnDirector
- Brian WhorleyExecutive Officer, Director
- Offering amount
- $35.5M
- Amount sold
- $32.8M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3.9MraisedOct 2020 · 8 investors · Business ServicesRule 506(b)
- Andy CloydDirector
- Brian WhorleyExecutive Officer, Director
- Offering amount
- $3.9M
- Amount sold
- $3.9M
- Minimum investment
- $1
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Paytient is a Columbia, Missouri-based healthcare fintech that develops Health Payment Accounts (HPAs), a sponsored benefit designed to help people pay out-of-pocket healthcare expenses. Employers, health systems and insurers contract with Paytient to offer HPAs to their employees and members. A member activates a Paytient Visa card without a credit check and uses it to pay a provider; Paytient pays the provider in full and the member then sets up a repayment plan in the Paytient app with no interest and no fees.
Repayment can be made via payroll deduction, a bank account of the member's choice, or from HSA and FSA funds, and card sponsors are not responsible for unpaid balances. The card program operates in partnership with Commerce Bank. Alongside the payment product, Paytient provides sponsors with dashboards and reporting on out-of-pocket spending trends intended to inform benefit plan design. The company describes its positioning around a "Better Care Economy" concept and markets separately to employers, brokers and consultants, insurers, healthcare providers, and individuals. Company materials also reference an expansion into prescription benefits involving GoodRx and Mark Cuban Cost Plus Drug Company.
Founding story
Brian Whorley spent roughly two decades working in his local hospital and observed patients absorbing a growing share of care costs, with paying for care becoming as difficult as the illness itself. In 2018 he and Daniel Lynn launched Paytient with the stated goal of enabling access to care without financial harm; the company describes its start as bootstrapped.
Business model
Paytient sells its Health Payment Account as a sponsored benefit to employers, health systems and insurers, which subscribe to provide the accounts to their employees and members. Paytient advances payment to healthcare providers at the point of sale and collects repayment from members over time without charging interest or fees; card sponsors do not bear responsibility for unpaid balances.
Sources describe employers, health systems and insurers subscribing to provide Health Payment Accounts to their populations, with the benefit characterized as low-cost to the sponsor and interest- and fee-free to the member. Sources do not detail specific pricing.
Traction
As of the January 2023 Series B, Paytient reported nearly 700 enterprise partners, 700,000 lives on the platform, an average NPS of 90, and nearly 400,000 card transactions since launch. Company materials state Paytient has put over $2 billion in healthcare purchasing power into members' hands and facilitated over $500 million in out-of-pocket healthcare spend. Self-reported member survey figures include 97% saying Paytient relieves financial stress.
Latest developments
Company and third-party listings reference an expansion into prescription benefits in partnership with GoodRx and Mark Cuban Cost Plus Drug Company, recognition in the 2026 MedTech Breakthrough Awards and by Modern Healthcare, and the appointment of Dr. Trent Haywood as Chief Outcomes Officer.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
The company reported nearly 700 enterprise partners and 700,000 lives on the platform at the time of its January 2023 Series B, and describes itself as offering healthcare affordability and payment infrastructure. Fierce Healthcare identified patient billing platform Cedar and "care now, pay later" provider PayZen as companies following similar models, noting PayZen integrates into provider revenue cycle management systems.
Paytient's stated points of difference are the absence of credit checks, interest and fees; provider payment in full at the point of service; member-selected repayment timelines and funding sources including HSA/FSA; sponsor non-liability for unpaid balances; and spending analytics returned to the benefit sponsor. Company materials cite a net promoter score of 90 in 2023 and 84 in 2026 materials.
Technology
The product combines a Paytient Visa card issued without a credit check with a mobile app in which members select repayment timelines and funding sources, including payroll deduction, bank accounts, HSAs and FSAs. Transaction data feeds an employer-facing dashboard that reports out-of-pocket spending trends, plan optimization insights and engagement metrics. Commerce Bank is named as the banking partner behind the platform.
Go-to-market
Paytient sells through multiple channels aligned to distinct audiences on its site: direct enterprise sales to employers and health systems, distribution via brokers and benefits consultants who add the product to client portfolios, and partnerships with insurers that embed affordability into plan designs. The company also publishes customer stories and benefits guides as sales collateral.
Self-funded and other employers, brokers and benefits consultants, health insurers and carriers, health systems and healthcare providers, and individual members receiving the benefit through a sponsor. Named partners and customers include Centene, Cigna, Coupe Health, Beta Health, R.R. Donnelley, EquipmentShare, Stephens College, Merrillville Community School Corporation and Shasta Industries.
Geography
United States. Paytient's headquarters is in Columbia, Missouri, with a primarily remote workforce that gathers periodically; it describes enterprise partners nationwide.
History
Paytient was founded in 2018 in Columbia, Missouri by Brian Whorley and Daniel Lynn. It raised Seed and Series A rounds led by Inspired Capital, and in January 2023 announced a Series B. The company's Series B announcement was originally published as a $40.5 million round including a $7.5 million Silicon Valley Bank credit facility; that facility ultimately did not close and the post was corrected in March 2023 to reflect $33 million in equity and $55.5 million in total funding. Paytient has been part of the Missouri Innovation Center portfolio of local startup successes. Its executive team has expanded to include a chief technology officer, chief growth officer, chief marketing officer, chief financial officer, chief outcomes officer, chief people officer and general counsel.
Risks & controversies
Paytient publicly corrected its Series B announcement in March 2023 after initially reporting a $40.5 million round that included a $7.5 million Silicon Valley Bank credit facility which did not close; contemporaneous press coverage (Fierce Healthcare, January 2023) reported the larger $40 million figure and a $63 million total. Many performance and satisfaction statistics available are self-reported by the company.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 6
by search overlapCompanies competing with Paytient for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 7
launches, deals, and filingsPaytient announced an expansion into prescription benefits pairing its payment capability with GoodRx and Mark Cuban Cost Plus Drug Company to address rising drug costs.
Paytient announced Dr. Trent Haywood, previously involved with the company for several years, as Chief Outcomes Officer; he is listed on the company's executive team page.
Series B equity round led by Mercato Partners Traverse Fund with participation from Bertelsmann Investments and existing investors. Joe Kaiser of Mercato joined the board; Thorsten Wirkes of Bertelsmann Investments joined as a board observer. An initially announced $40.5M figure included a $7.5M Silicon Valley Bank credit facility that did not close; the announcement was corrected on 2023-03-15.
$33M source ↗
Mercato Partners Traverse Fund managing director Joe Kaiser joined Paytient's board of directors and Thorsten Wirkes of Bertelsmann Investments joined as an observer in connection with the Series B.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structureIn the news
▸Research sources · 8
primary sources listed
- Paytientpaytient.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Paytient do?
- Paytient provides employer- and insurer-sponsored Health Payment Accounts that let members pay out-of-pocket medical costs over time, interest-free.
- Who founded Paytient?
- Paytient was founded by Brian Whorley, Daniel Lynn in 2018.
- Who are Paytient's investors?
- Paytient's investors include Felicis Ventures, Inspired Capital, Mercato Partners, Bertelsmann Investments, Cultivation Capital, Left Lane Capital, Lightbank.
- How much funding has Paytient raised?
- Paytient has disclosed $53.9M raised across 3 of its 4 known rounds.
- Where is Paytient headquartered?
- Paytient is headquartered in Columbia, US.





.png)
